Mereo BioPharma (UK) Market Value
| 0A9G Stock | 3.55 0.15 4.41% |
| Symbol | Mereo |
Mereo BioPharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mereo BioPharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mereo BioPharma.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Mereo BioPharma on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Mereo BioPharma Group or generate 0.0% return on investment in Mereo BioPharma over 30 days. Mereo BioPharma is related to or competes with Uniper SE, Mulberry Group, London Security, Triad Group, World Chess, SURETRACK MON, and Heavitree Brewery. Mereo BioPharma is entity of United Kingdom More
Mereo BioPharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mereo BioPharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mereo BioPharma Group upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 17.99 | |||
| Value At Risk | (6.05) | |||
| Potential Upside | 5.4 |
Mereo BioPharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mereo BioPharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mereo BioPharma's standard deviation. In reality, there are many statistical measures that can use Mereo BioPharma historical prices to predict the future Mereo BioPharma's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.58) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (0.30) |
Mereo BioPharma Group Backtested Returns
Mereo BioPharma Group has Sharpe Ratio of -0.0871, which conveys that the firm had a -0.0871% return per unit of risk over the last 3 months. Mereo BioPharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mereo BioPharma's Mean Deviation of 2.96, risk adjusted performance of (0.07), and Standard Deviation of 3.86 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.35, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mereo BioPharma will likely underperform. At this point, Mereo BioPharma Group has a negative expected return of -0.34%. Please make sure to verify Mereo BioPharma's information ratio, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Mereo BioPharma Group performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.34 |
Poor reverse predictability
Mereo BioPharma Group has poor reverse predictability. Overlapping area represents the amount of predictability between Mereo BioPharma time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mereo BioPharma Group price movement. The serial correlation of -0.34 indicates that nearly 34.0% of current Mereo BioPharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.34 | |
| Spearman Rank Test | -0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Mereo BioPharma Group lagged returns against current returns
Autocorrelation, which is Mereo BioPharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mereo BioPharma's stock expected returns. We can calculate the autocorrelation of Mereo BioPharma returns to help us make a trade decision. For example, suppose you find that Mereo BioPharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mereo BioPharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mereo BioPharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mereo BioPharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mereo BioPharma stock over time.
Current vs Lagged Prices |
| Timeline |
Mereo BioPharma Lagged Returns
When evaluating Mereo BioPharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mereo BioPharma stock have on its future price. Mereo BioPharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mereo BioPharma autocorrelation shows the relationship between Mereo BioPharma stock current value and its past values and can show if there is a momentum factor associated with investing in Mereo BioPharma Group.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Mereo Stock Analysis
When running Mereo BioPharma's price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.